Join us for ongoing discussions with our clinician-bloggers,
Paul Sax, MD
HIV and ID Observations
An ongoing dialogue on HIV/AIDS, infectious diseases,
all matters medical, and some not so medical
Recent Posts
Anal Cancer Screening in HIV: When Guidelines Get Ahead of the Evidence • August 16, 2025
Should every person with HIV over age 35 (if MSM or transgender woman) or 45 (everyone else) have an anal Pap smear, a digital anal rectal exam (DARE), and possibly a high-resolution anoscopy every 1–2 years? According to recent guidelines, yes. But here’s the problem: we don’t know if this screening effort actually prevents cancer. First, […]
2021-2022
Chief Resident Panel:
Abdullah Al‑abcha, MD
Mikita Arora, MD
Madiha Khan, DO
Mikita Arora, MD
Khalid A. Shalaby, MBBCh
Brandon Temte, DO
Insights on Residency Training
Notes from chief residents in family and internal medicine
Recent Posts
Developing Resident Educators • August 19, 2022 • Brandon Temte, DO
We currently find ourselves at the start of another academic year. By this time in August, many medical trainees are settling into new roles. Recently graduated medical students are getting used to hearing Dr. before their name. New senior residents who were interns a short time ago now find themselves leaders of their own teams. […]
Follow us on:
Apple Podcasts
YouTube
Spotify
Clinical Conversations
This podcast features lively interviews, concise summaries, and expert commentary that busy clinicians need to stay current and improve patient care.
Recent Posts
Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2 • September 2, 2022
A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE AT THIS LINK. In treating most exacerbations of chronic obstructive pulmonary disease (COPD) the usual regimen consists of prednisone plus 5- to 7-days of antibiotics. But what if a shorter course of antibiotic therapy would do? That would be both convenient for patients and less likely to promote […]
The post Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2 first appeared on Clinical Conversations.Statements and opinions expressed in these blogs reflect the views of the author(s) and not necessarily the official policy of NEJM Journal Watch, NEJM Group, or the Massachusetts Medical Society, unless so stated.
NEJM Journal Watch — Recent Infectious Diseases Articles- Could a Virus Cause Some Cases of Parkinson Disease?
- What's the Optimal Dosing of Linezolid for Rifampin-Resistant and Multidrug-Resistant TB?
- What to Do After Virologic Failure on First-Line Therapy with a Nonnucleoside Reverse Transcriptase Inhibitor?
- Another Flu Virus Crosses the Species Border
- Observations from ID and Beyond: Does the Fact That AI Is Brilliant at Writing “Learning Objectives” Prove They're Not Really Needed?
- NEJM Journal Watch — Recent General Medicine Articles
- How Well Do Adults Understand Aspirin's Harms and Benefits?
- More Data on Suzetrigine, a Novel Nonopioid Pain Medication
- Cardiovascular Safety of Colchicine vs. NSAIDs for Anti-Inflammatory Prophylaxis in Patients with Gout
- Large Language Models and Clinical Reasoning: The Frontier in 2025
- Meclizine Use Is Associated with Excess Risk for Injurious Falls